winona semaglutide U.S. FDA finds no evidence yet linking weight-loss drugs to suicidal thoughts high blood pressure Demand Rising for 'Bootlegged' Weight-Loss

Experts emphasize that people should not start or stop medications solely for brain health without talking to a healthcare provider and that lifestyle factors (healthy diet, physical activity, and blood sugar control) remain critical in dementia prevention

8 CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity, currently in Phase I, with the potential to be a best-in-class oral treatment for type 2 diabetes and chronic weight management

Depending on the formulation and your health goals, IV therapy frequency can vary from weekly to monthly

A consultation with our medical team and comprehensive cognitive assessment are required to determine if this therapy is appropriate for you.